TURNOVER (x1000 NOK)
NET PROFIT (x1000 NOK)
EMPLOYEES
SVAR Life Science AB
Closing information (x1000 NOK)
| Closing information | 2023/12 (consolidated) | 2022/12 (consolidated) | 2021/12 (consolidated) |
| Turnover |
286,355
|
251,412
|
216,395 |
| Financial expenses |
11,633
|
7,660
|
6,708 |
| Earnings before taxes |
47,754
|
42,809
|
-34,325 |
| EBITDA |
50,595
|
45,196
|
37,811 |
| Total assets |
318,569
|
264,641
|
237,596 |
| Current assets |
224,731
|
164,580
|
100,344 |
| Current liabilities |
58,578
|
55,558
|
50,413 |
| Equity capital |
237,445
|
184,143
|
146,995 |
| - share capital |
297
|
277
|
286 |
| Employees (average) |
122
|
120
|
123 |
Financial ratios
| Fiscal year | 2023/12 (consolidated) | 2022/12 (consolidated) | 2021/12 (consolidated) |
| Solvency |
74.5%
|
69.6%
|
61.9% |
| Turnover per employee |
2,347
|
2,095
|
1,759 |
| Profit as a percentage of turnover |
16.7%
|
17.0%
|
-15.9% |
| Return on assets (ROA) |
18.6%
|
19.1%
|
-11.6% |
| Current ratio |
383.6%
|
296.2%
|
199.0% |
| Return on equity (ROE) |
20.1%
|
23.2%
|
-23.4% |
| Change turnover |
17,103
|
41,521
|
15,137 |
| Change turnover % |
6%
|
20%
|
8% |
| Chg. No. of employees |
2
|
-3
|
33 |
| Chg. No. of employees % |
2%
|
-2%
|
37% |
Total value of public sale
| Fiscal year | 2023/12 (consolidated) | 2022/12 (consolidated) | 2021/12 (consolidated) |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.